BioCentury
ARTICLE | Company News

Affomix, City of Hope National Medical Center deal

January 25, 2010 8:00 AM UTC

Affomix will use its Y2Hexpress and Phage ESCape technologies to develop antibodies for City of Hope. The hospital will use the antibodies with next-generation sequencers to develop proteomic profiles...